NHANES has collected data on eating patterns, diabetes, and other common diseases for decades. The CDC team that runs it has ...

Biocryst Pharmaceuticals is acquiring Astria Therapeutics in a cash-and-stock deal with a $700 million enterprise value. The ...

Investors announced one of the biggest private financing rounds of the year for a biotech company, pouring $600 million into ...

A troubled Indiana contract manufacturing plant recently acquired by Novo Nordisk is considered to not be in compliance with ...

Robert F. Kennedy Jr.’s tenure atop HHS has been marked by increasing tension between career scientists and political leaders ...

Current and former FDA staff said the level of involvement of political officials in nitty-gritty regulatory matters is ...

Lyra Health has launched a "clinical-grade" chatbot amid growing concern about mental health and artificial intelligence.

The startup Altitude is seeking to use AI to supercharge the skills of nurse practitioners, a growing workforce that is ...

Animals used in research aren’t just hidden from sight. They’re objectified, or “de-animalized,” as Melanie D.G. Kaplan ...

Welcome to Neurotransmissions, a new First Opinion column on the revolution in dementia. This is the second in a three-part ...

The FDA has declared a Novo Nordisk plant, key to drug manufacturing for some biotechs, out of compliance, which could delay ...

Hypertension notifications, alongside the growing suite of health metrics in the Apple ecosystem, are not population health ...